Finance

Beta
Lists
002082:SHE
Wanbangde Pharmaceuticl Hldng Grp Co Ltd
CN¥15.40
-5.00%
(-0.81) 1D
May 21, 3:04:54 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002082...
Open
CN¥15.40
High
CN¥16.18
Low
CN¥15.40
Mkt. cap
9.92B
Avg. vol.
31.47M
Volume
54.71M
52-wk high
CN¥36.24
52-wk low
CN¥5.51
EPS
-CN¥0.13
Shares outstanding
611.69M
No. of employees
1K
News stories
From sources across the web
About Wanbangde Pharmaceuticl Hldng Grp Co Ltd
CEO-
Employees1.35K
Founded1985
Headquarters-
SectorPharmaceutical industry
Websitechinawepon.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
263.44M
439.15M
99.62M
374.21M
Cost of goods sold
183.64M
296.93M
37.91M
161.35M
Cost of revenue
183.64M
296.93M
37.91M
161.35M
Research and development expenses
18.37M
18.12M
9.90M
11.47M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
89.60M
112.01M
93.78M
80.55M
Operating expense
132.76M
145.02M
92.30M
95.10M
Total operating expenses
316.39M
441.96M
130.21M
256.44M
Operating income
-52.95M
-2.80M
-30.60M
117.77M
Other non operating income
-2.77M
2.27M
-101.64M
14.44M
EBT including unusual items
-14.46M
-9.16M
-159.75M
129.35M
EBT excluding unusual items
-61.49M
-11.11M
-108.60M
132.21M
Income tax expense
-12.02M
-1.66M
13.43M
28.69M
Effective tax rate
83.11%
18.11%
-8.41%
22.18%
Other operating expenses
31.56M
4.87M
-4.06M
3.07M
Net income
-1.74M
-9.00M
-171.70M
102.95M
Net profit margin
-0.66%
-2.05%
-172.36%
27.51%
Earnings per share
-
-
-
-
Interest and investment income
5.20M
-
23.64M
-
Interest expense
-11.93M
-9.61M
-
-
Net interest expenses
-6.73M
-9.61M
23.64M
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-27.13M
21.11M
-3.11M
145.26M
Gain or loss from assets sale
-297.90K
297.90K
-600.48K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer